IN2014DN10680A - - Google Patents

Download PDF

Info

Publication number
IN2014DN10680A
IN2014DN10680A IN10680DEN2014A IN2014DN10680A IN 2014DN10680 A IN2014DN10680 A IN 2014DN10680A IN 10680DEN2014 A IN10680DEN2014 A IN 10680DEN2014A IN 2014DN10680 A IN2014DN10680 A IN 2014DN10680A
Authority
IN
India
Prior art keywords
polymorphic forms
crystalline polymorphic
respiratory
disease
mdt
Prior art date
Application number
Other languages
English (en)
Inventor
Robert O Cook
Eugene R Reynolds
Boris Shekunov
Siead I Zegar
Original Assignee
Microdose Therapeutx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdose Therapeutx Inc filed Critical Microdose Therapeutx Inc
Publication of IN2014DN10680A publication Critical patent/IN2014DN10680A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN10680DEN2014 2012-06-29 2013-06-28 IN2014DN10680A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261666258P 2012-06-29 2012-06-29
PCT/US2013/048723 WO2014005098A2 (fr) 2012-06-29 2013-06-28 Compositions et méthodes de traitement ou de prévention d'une infection par un pneumovirus et de maladies associées

Publications (1)

Publication Number Publication Date
IN2014DN10680A true IN2014DN10680A (fr) 2015-08-28

Family

ID=49778754

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10680DEN2014 IN2014DN10680A (fr) 2012-06-29 2013-06-28

Country Status (17)

Country Link
US (2) US9040569B2 (fr)
EP (1) EP2867216A4 (fr)
JP (1) JP2015524391A (fr)
KR (1) KR20150037946A (fr)
CN (1) CN104507918A (fr)
AU (1) AU2013282286A1 (fr)
BR (1) BR112014032290A2 (fr)
CA (1) CA2877941A1 (fr)
EA (1) EA201590124A1 (fr)
HK (2) HK1203956A1 (fr)
IL (1) IL236476A0 (fr)
IN (1) IN2014DN10680A (fr)
MX (1) MX2014015340A (fr)
NZ (1) NZ628880A (fr)
TW (1) TWI516283B (fr)
WO (1) WO2014005098A2 (fr)
ZA (1) ZA201409073B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014032290A2 (pt) 2012-06-29 2017-06-27 Microdose Therapeutx Inc composições e métodos para tratar ou prevenir infecção de pneumovírus e doenças associadas.
WO2016096143A1 (fr) * 2014-12-18 2016-06-23 Metriopharm Ag Forme cristalline du sel de sodium de 5-amino-2,3-dihydrophtalazine-1,4-dione, préparations pharmaceutiques la contenant et procédés pour sa production
MX2018006575A (es) * 2015-11-30 2018-12-06 Novus Therapeutics Inc Composiciones y metodos para profilaxis otologica y tratamiento.
WO2018071445A1 (fr) 2016-10-11 2018-04-19 Microdose Therapeutx, Inc. Inhalateur et ses méthodes d'utilisation
KR20210046018A (ko) * 2018-09-14 2021-04-27 파모사 바이오팜 인코포레이티드 약산성 약물의 방출 제어를 위한 약제학적 조성물 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495580B1 (en) * 1998-01-29 2002-12-17 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
NZ505894A (en) 1998-01-29 2002-12-20 Viropharma Inc Methylenebisbenzaldehyde derivatives, methylidynetrisphenol derivative and pharmaceuticals thereof; useful for treating or preventing pneumovirus infection and associated diseases
WO2002059132A1 (fr) 2001-01-26 2002-08-01 Viropharma Incorporated Composes intermediaires se pretant a la fabrication de composes antiviraux
EP1539691A2 (fr) 2002-08-09 2005-06-15 Viropharma Incorporated Composes, compositions et methodes de traitement ou de prevention d'infections pneumovirales et de maladies connexes
CA2495266A1 (fr) 2002-08-09 2004-02-19 Viropharma Incorporated Composes, compositions et techniques de traitement et de prevention de l'infection par des pneumovirus et de maladies associees
BR112014032290A2 (pt) 2012-06-29 2017-06-27 Microdose Therapeutx Inc composições e métodos para tratar ou prevenir infecção de pneumovírus e doenças associadas.

Also Published As

Publication number Publication date
WO2014005098A3 (fr) 2014-02-27
IL236476A0 (en) 2015-02-26
CA2877941A1 (fr) 2014-01-03
US9040569B2 (en) 2015-05-26
US20140005239A1 (en) 2014-01-02
EA201590124A1 (ru) 2015-06-30
WO2014005098A2 (fr) 2014-01-03
NZ628880A (en) 2016-08-26
CN104507918A (zh) 2015-04-08
TW201416093A (zh) 2014-05-01
AU2013282286A1 (en) 2015-01-22
ZA201409073B (en) 2016-08-31
JP2015524391A (ja) 2015-08-24
EP2867216A4 (fr) 2015-12-09
EP2867216A2 (fr) 2015-05-06
BR112014032290A2 (pt) 2017-06-27
KR20150037946A (ko) 2015-04-08
MX2014015340A (es) 2015-03-05
TWI516283B (zh) 2016-01-11
US9504672B2 (en) 2016-11-29
HK1203956A1 (en) 2015-11-06
US20150209328A1 (en) 2015-07-30
HK1210163A1 (en) 2016-04-15

Similar Documents

Publication Publication Date Title
EP2751060A4 (fr) Procédé pour la production à la fois d'acide succinique et d'acide 2,5-furandicarboxylique biosourcés
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
PL2630108T3 (pl) Sposób wytwarzania 2,3,3,3-tetrafluoropropenu
IL230635A (en) An outgrowth of 4,3,2,1-tetrahydroquinoline used to treat diabetes
WO2012025944A3 (fr) Sitagliptine, sels et polymorphes de celle-ci
IL216935A0 (en) Process for the preparation of nacre mechano-structured by mechanosynthesis, mechano-structured nacre thus obtained and uses thereof
FR2962731B1 (fr) Procede de preparation de derives d'amino-benzoyl-benzofurane
WO2014072961A3 (fr) Formes polymorphes du suvorexant
IN2014DN10680A (fr)
ZA201404440B (en) Process for the preparation of travoprost
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
WO2015068175A3 (fr) Procédé perfectionné de préparation de pazopanib ou d'un sel de qualité pharmaceutique de celui-ci
HK1199242A1 (zh) 生產 -丁二烯的方法
EA201300647A1 (ru) Оптимизированный синтез чистых неполиморфных кристаллических жёлчных кислот с заданным размером частиц
WO2010079045A3 (fr) Nouveaux sels
NZ720340A (en) Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulene and crystalline forms thereof
WO2015052568A3 (fr) Formes solides de curcumine et de dérivés de curcumine
HK1223334A1 (zh) 製造植入物或該植入物的中間產品的方法以及通過該方法獲得的植入物和中間產品
WO2011100282A3 (fr) Polymorphes de mésylate d'imatinib
WO2014178064A3 (fr) Procédé amélioré de préparation de maléate de fluvoxamine
SG11201405376TA (en) CRYSTALLINE FORMS OF 5α-ANDROSTANE-3β, 5, 6β-TRIOL AND PREPARATION METHODS THEREOF
WO2013114397A3 (fr) Sel pharmaceutiquement acceptable de brinzolamide et composition de celui-ci
WO2014102820A3 (fr) Intermédiaire du rivaroxaban et sa préparation
WO2015001565A3 (fr) "procédé amélioré pour la préparation de 3-aryloxy-3- phénylpropylamine et son sel"
HK1199884A1 (en) Method for producing cereulide and derivative thereof, intermediate for production of cereulide, and cereulide derivative cereulide cereulide cereulide